A meta-analysis analyzing the efficacy and safety of datopotamab deruxtecan (Dato-DXd) in previously treated patients with non-small cell lung cancer (NSCLC). SVs in targetable genes CH SVs in WBC, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results